Discrimination and net-reclassification of cardiovascular disease risk with Lipoprotein(a) levels: The ATTICA study (2002–2022)

Post time 3 day(s) ago

journal：Journal of Clinical Lipidology

Authors：Sofia-Panagiota Giannakopoulou; Christina Chrysohoou; Smaragdi Antonopoulou; Evangelia Damigou; Fotios Barkas; Christina Vafia; Evrydiki Kravvariti; Costas Tsioufis; Christos Pitsavos; Evangelos Liberopoulos; Petros P. Sfikakis; Demosthenes Panagiotakos

Published date：2024-4-

DOI：10.1016/j.jacl.2024.04.126

PDF link：https://www.sciencedirect.com/sc ... 933287424001740/pdf

Article link：http://dx.doi.org/10.1016/j.jacl.2024.04.126

Article Source：Elsevier BV。

Remark：

Post time 3 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Discrimination and net-reclassification of cardiovascular disease risk with Lipoprotein(a) levels: The ATTICA study (2002–2022)

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Discrimination and net-reclassification of cardiovascular disease risk with Lipoprotein(a) levels: The ATTICA study (2002–2022) Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Discrimination and net-reclassification of cardiovascular disease risk with Lipoprotein(a) levels: The ATTICA study (2002–2022)